Photgraph of Lance Baldo, MD

Lance Baldo, MD

Chief Medical Officer

Dr. Lance Baldo, MD, has served as Adaptive’s Chief Medical Officer since May 2019. From February 2010 to April 2019, Lance served in various roles of ascending responsibility with the Roche Group and its affiliates, including most recently as Senior Vice President and Head of U.S. Medical Affairs of Genentech. Prior to joining the Roche Group, Lance served as Vice President, Global Medical Science and Affairs at The Medicines Company, a public biopharmaceuticals company, from September 2005 to February 2010. Lance holds an MD from the University of Connecticut School of Medicine and a BA in Biology from Johns Hopkins University.